Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice

Here we report on the impact of completely unpurified islet transplantation on the portal vein pressure (PVP) and the hepatic biochemistry in the peritransplant period and on follow-up. Type I diabetic patients underwent simultaneous kidney and islet transplantation. Islets were not purified from th...

Full description

Bibliographic Details
Main Authors: Sung Ho Hyon, María Candela Ceballos, Mariana Barbich, Rosana Groppa, Luis Grosembacher, María Mercedes Vieiro, Laura Barcan, Salomon Algranati, Leon Litwak, Pablo F. Argibay M.D., Ph.D.
Format: Article
Language:English
Published: SAGE Publishing 2004-01-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/000000004772664905
id doaj-dfe2a304e3db4294a3e73834671109dd
record_format Article
spelling doaj-dfe2a304e3db4294a3e73834671109dd2020-11-25T04:00:21ZengSAGE PublishingCell Transplantation0963-68971555-38922004-01-011310.3727/000000004772664905Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical PracticeSung Ho Hyon0María Candela Ceballos1Mariana Barbich2Rosana Groppa3Luis Grosembacher4María Mercedes Vieiro5Laura Barcan6Salomon Algranati7Leon Litwak8Pablo F. Argibay M.D., Ph.D.9Kidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaKidney and Pancreas Transplantation Program, Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires (1181), ArgentinaHere we report on the impact of completely unpurified islet transplantation on the portal vein pressure (PVP) and the hepatic biochemistry in the peritransplant period and on follow-up. Type I diabetic patients underwent simultaneous kidney and islet transplantation. Islets were not purified from the acinar tissue to prevent loss of endocrine mass. Each patient received a mean 521,846 ± 201,539.4 islet equivalents (7812.1 islet equivalents/kg/recipient). Immunosuppression and peritransplant medication were given according to the Giessen protocol. The islets were injected into the left hepatic lobe through the umbilical vein. PVP was recorded at time 0 and every 5 min throughout cell infusion. Liver function was assessed daily for the first 10 days, and on follow-up. Basal, peak, and final PVP were 12 ± 3.8, 25.1 ± 7.9, and 19.5 ± 6.2 mmHg, respectively (basal vs. final, p < 0.05). Bilirubin, alkaline phosphatase, prothrombin time, and APTT stayed within normal range. Peak aspartate aminotransferase (AST), alanine aminotransferase (ALT), and serum amylase were 109.4 ± 61.2 IU/L (basal vs. peak, not significant), 79.5 ± 56.9 IU/L (basal vs. peak, not significant), and 887.5 ± 153.6 IU/L (basal vs. peak, p = 0.02), respectively. In all cases AST, ALT, and amylase normalized within 6 days posttransplant and remained so on follow-up (longest control, 33 months posttransplant). Although the intrahepatic infusion of unpurified pancreatic islets affects both the portal vein pressure and the hepatic biochemical profile, this effect is transient and does not compromise the safety of the procedure.https://doi.org/10.3727/000000004772664905
collection DOAJ
language English
format Article
sources DOAJ
author Sung Ho Hyon
María Candela Ceballos
Mariana Barbich
Rosana Groppa
Luis Grosembacher
María Mercedes Vieiro
Laura Barcan
Salomon Algranati
Leon Litwak
Pablo F. Argibay M.D., Ph.D.
spellingShingle Sung Ho Hyon
María Candela Ceballos
Mariana Barbich
Rosana Groppa
Luis Grosembacher
María Mercedes Vieiro
Laura Barcan
Salomon Algranati
Leon Litwak
Pablo F. Argibay M.D., Ph.D.
Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice
Cell Transplantation
author_facet Sung Ho Hyon
María Candela Ceballos
Mariana Barbich
Rosana Groppa
Luis Grosembacher
María Mercedes Vieiro
Laura Barcan
Salomon Algranati
Leon Litwak
Pablo F. Argibay M.D., Ph.D.
author_sort Sung Ho Hyon
title Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice
title_short Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice
title_full Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice
title_fullStr Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice
title_full_unstemmed Effect of the Embolization of Completely Unpurified Islets on Portal Vein Pressure and Hepatic Biochemistry in Clinical Practice
title_sort effect of the embolization of completely unpurified islets on portal vein pressure and hepatic biochemistry in clinical practice
publisher SAGE Publishing
series Cell Transplantation
issn 0963-6897
1555-3892
publishDate 2004-01-01
description Here we report on the impact of completely unpurified islet transplantation on the portal vein pressure (PVP) and the hepatic biochemistry in the peritransplant period and on follow-up. Type I diabetic patients underwent simultaneous kidney and islet transplantation. Islets were not purified from the acinar tissue to prevent loss of endocrine mass. Each patient received a mean 521,846 ± 201,539.4 islet equivalents (7812.1 islet equivalents/kg/recipient). Immunosuppression and peritransplant medication were given according to the Giessen protocol. The islets were injected into the left hepatic lobe through the umbilical vein. PVP was recorded at time 0 and every 5 min throughout cell infusion. Liver function was assessed daily for the first 10 days, and on follow-up. Basal, peak, and final PVP were 12 ± 3.8, 25.1 ± 7.9, and 19.5 ± 6.2 mmHg, respectively (basal vs. final, p < 0.05). Bilirubin, alkaline phosphatase, prothrombin time, and APTT stayed within normal range. Peak aspartate aminotransferase (AST), alanine aminotransferase (ALT), and serum amylase were 109.4 ± 61.2 IU/L (basal vs. peak, not significant), 79.5 ± 56.9 IU/L (basal vs. peak, not significant), and 887.5 ± 153.6 IU/L (basal vs. peak, p = 0.02), respectively. In all cases AST, ALT, and amylase normalized within 6 days posttransplant and remained so on follow-up (longest control, 33 months posttransplant). Although the intrahepatic infusion of unpurified pancreatic islets affects both the portal vein pressure and the hepatic biochemical profile, this effect is transient and does not compromise the safety of the procedure.
url https://doi.org/10.3727/000000004772664905
work_keys_str_mv AT sunghohyon effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice
AT mariacandelaceballos effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice
AT marianabarbich effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice
AT rosanagroppa effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice
AT luisgrosembacher effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice
AT mariamercedesvieiro effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice
AT laurabarcan effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice
AT salomonalgranati effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice
AT leonlitwak effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice
AT pablofargibaymdphd effectoftheembolizationofcompletelyunpurifiedisletsonportalveinpressureandhepaticbiochemistryinclinicalpractice
_version_ 1724451190214754304